1-4 of 4
Michael D. Jain, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Copy Number Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma

Christopher Rushton, BSc, Miguel Alcaide, PhD, Matthew Cheung, BSc, Neil R Michaud, Scott Daigle, Ryan N Rys, BSc, BA, Sarah E Arthur, BSc, Marquisa Zrymiak, BSc, Jordan Davidson, BSc, Kevin R Bushell, BSc, MSc, Stephen Yu, MSc, Michael D. Jain, MDPhD, Lois E. Shepherd, Marco A. Marra, PhD, John Kuruvilla, MD, Michael Crump, MD, Koren Kathleen Mann, PhD, Sarit E Assouline, MD MSc, Joseph M. Connors, MD, Christian Steidl, MD, Nathalie A Johnson, MD PhD, David W. Scott, MBChB, PhD, Ryan D Morin, PhDBSc,MSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-142871
Published: 2020
Journal Articles

Factors Affecting Lymphocyte Collection Efficiency and Manufactured Product Specification during Leukapheresis for Diffuse Large B Cell Lymphoma Patients Treated with Commercial Tisagenlecleucel

Ariel Perez Perez, MD, Christina A Bachmeier, PharmD, Renee Smilee, Albert J Ribickas, Aleksandr Lazaryan, MDPhDMPH, Julio C. Chavez, MD, Claudio Anasetti, MD, Bijal Shah, MD, Farhad Khimani, MBBS, Taiga Nishihori, MD, Marco L. Davila, MD PhD, Frederick L. Locke, MD, Michael D. Jain, MDPhD, Hien D. Liu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-143336
Published: 2020
Journal Articles

Axicabtagene Ciloleucel (Axi-cel) CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World Experience

Loretta J. Nastoupil, MD, Michael D. Jain, MDPhD, Jay Y. Spiegel, MD, Armin Ghobadi, MD, Yi Lin, MD PhD, Saurabh Dahiya, MD, Matthew A. Lunning, DO, Lazaros J. Lekakis, MD, Patrick M. Reagan, MD, Olalekan O. Oluwole, MBBS, MPH, Joseph P. McGuirk, DO, Abhinav Deol, MD, Alison R. Sehgal, MD, Andre Goy, MD, Brian T. Hill, MD PhD, Charalambos Andreadis, MD, Javier Munoz, MD, Jason R. Westin, MD, Julio C. Chavez, MD, Amanda F Cashen, MD, Nora N Bennani, MD, Aaron P. Rapoport, MD, Julie M. Vose, MDMBA, David B. Miklos, MD PhD, Sattva S. Neelapu, MD, Frederick L. Locke, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 91.
https://doi.org/10.1182/blood-2018-99-114152
Published: 2018
Journal Articles

Prediction of CAR T-Related Toxicities in R/R DLBCL Patients Treated with Axicabtagene Ciloleucel Using Point of Care Cytokine Measurements

Rawan Faramand, MD, Hiroshi Kotani, MD PhD, Dylan Morrissey, Bin Yu, Frederick L. Locke, MD, Michael D. Jain, MDPhD, Julio C. Chavez, MD, Xuefeng Wang, PhD, Asmita Mishra, MD, Christina A Bachmeier, PharmD, Renier J. Brentjens, MD PhD, Sarah Yoo, Jae H. Park, MD, Marco L. Davila, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 95.
https://doi.org/10.1182/blood-2018-99-116539
Published: 2018